Is combined calcium/magnesium phosphate binder really noninferior to sevelamer hydrochloride?

Nephrology Dialysis Transplantation

Volumn 26, Issue 4, 2011, Pages 1442-1443

  Spasovski, Goce ^a   Vanholder, Raymond ^b  

^a SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM ACETATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; MAGNESIUM CARBONATE; PARATHYROID HORMONE; PHOSPHATE BINDING AGENT; SEVELAMER; SEVELAMER CARBONATE;

ATHEROSCLEROSIS; BONE MINERALIZATION; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; HUMAN; LETTER; MAGNESIUM BLOOD LEVEL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL RATE;

CALCIUM PHOSPHATES; CHELATING AGENTS; HUMANS; KIDNEY FAILURE, CHRONIC; MAGNESIUM COMPOUNDS; PHOSPHATES; POLYAMINES; RENAL DIALYSIS;

EID: 79953005164     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq778     Document Type: Letter

References (7)

1. De Francisco A, Leidig M, Covic A et al. Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrol Dial Transplant 2010; 25: 3707-3717
2. Spasovski G, Massy Z, Vanholder R. Phosphate metabolism in chronic kidney disease: from pathophysiology to clinical management. Semin Dial 2009; 22: 357-362
3. Moe S, Drueke T, Cunningham J et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 69: 1945-1953 (Pubitemid 43924257)
4. KDIGO. Clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int 2009; 76: S1-S130
5. Kanbay M, Goldsmith D, Uyar ME et al. Magnesium in chronic kidney disease: challenges and opportunities. Blood Purif 2009; 29: 280-292
6. Navarro-Gonzalez JF, Mora-Fernandez C, Garcia-Perez J. Clinical implications of disordered magnesium homeostasis in chronic renal failure and dialysis. Semin Dial 2009; 22: 37-44
7. K/DOQI. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: S1-S201